Monte Rosa Therapeutics (GLUE) Liabilities and Shareholders Equity (2020 - 2026)
Monte Rosa Therapeutics (GLUE) recorded Liabilities and Shareholders Equity of $691.16 million in Q2 2026, up 92.2% from $359.59 million a year earlier but down 6.1% from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Monte Rosa Therapeutics reported Liabilities and Shareholders Equity of $448.66 million, up 2.3% from FY2024.
- Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 55.5% (FY2020 to FY2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $438.73 million in FY2024 (+44.4%), $303.76 million in FY2023 (-11.3%), $342.39 million in FY2022 (-6.5%) and $366.33 million in FY2021 (+641.9%).
- Quarterly Liabilities and Shareholders Equity has ranged from $252.1 million in Q3 2023 to $736.43 million in Q1 2026 over the past five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased for nine consecutive quarters, with growth averaging 43.6% over the last eight quarters.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 641.9% in Q4 2021, against a decline of 29.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $736.43 million (Q1 2026), $448.66 million (Q4 2025) and $459.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Monte Rosa Therapeutics | 1.02 Bn | 428.56 Mn | - | 691.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 691.16 Mn |
| Mar 31, 2026 | 736.43 Mn |
| Dec 31, 2025 | 448.66 Mn |
| Sep 30, 2025 | 459.84 Mn |
| Jun 30, 2025 | 359.59 Mn |
| Mar 31, 2025 | 393.20 Mn |
| Dec 31, 2024 | 438.73 Mn |
| Sep 30, 2024 | 315.08 Mn |
| Jun 30, 2024 | 344.11 Mn |
| Mar 31, 2024 | 266.75 Mn |
| Dec 31, 2023 | 303.76 Mn |
| Sep 30, 2023 | 252.10 Mn |
| Jun 30, 2023 | 278.62 Mn |
| Mar 31, 2023 | 309.03 Mn |
| Dec 31, 2022 | 342.39 Mn |
| Sep 30, 2022 | 357.60 Mn |
| Jun 30, 2022 | 365.06 Mn |
| Mar 31, 2022 | 346.01 Mn |
| Dec 31, 2021 | 366.33 Mn |
| Sep 30, 2021 | 384.05 Mn |
API Access
Monte Rosa Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();